Anxiety & Insomniaš«£š¤ Flashcards
(31 cards)
Psychological anxiety symptoms
Worrying thoughts, hard to control
Fearful anticipation
Poor memory
Insomnia
Poor concentration
Avoidance behaviours
Irritability
Sensitivity to noise and light
Physical anxiety symptoms
Palpitations, SOB
Tremor
Sexual difficulties
Problems with urinary/faecal excretion
Fatigue
Dizziness, headache
Poor swallowing / dry mouth
Name 3 types of anxiety disorders
Generalised anxiety disorder (GAD)
Panic disorder
Social phobia/ social anxiety disorder
Anxiety diagnosis
Differential diagnosis
Duration of symptoms and severity determines whether it is anxiety
General screening: GAD-2 (generalised anxiety scale) to see if further investigation is required.
GAD-2 questions: how often have you experienced the following over the last 2 weeks?
Feeling nervous / anxious/ on edge
Uncontrollable worrying
3+ = GAD-7
Generalised anxiety disorder (GAD) diagnosis
Specific symptoms:
Excessive worry about a number of issues most of the time (not restricted to specific issue)
Preoccupation/seeking reassurance for somatic symptoms or chronic physical health problem
Over arousal and irritability
Insomnia and poor concentration
Duration: 6 months +
Panic disorder diagnosis
Specific symptoms:
Worrying thoughts and fearful anticipation
Unforeseen abrupt surge of intense fear (panic attack)
Poor memory
Duration: Panic attack followed by one month of persistent worry about recurrence
Social anxiety / phobia disorder diagnosis
Specific symptoms:
Persistent and overwhelming fear of social situations that is out of proportion
Excessive worrying before, during and after
Duration: 6 months +
Mini social phobia inventory screening
GAD treatment
Psychological:
First line: psychological but may need pharmacological if more severe/ big impact
1) Education + active monitoring
2) Self-help (non-facilitated or guided eg appointments) + group education (if education didnāt work)
3) high intensity psychological intervention. CBT. Applied relaxation (last option if others not worked / marked functional impairment (moderate-severe)
Pharmacological therapy:
Offered to those who have marked functional impairment or education/self-help not effective (moderate-severe severity)
Treatment choice:
⢠Selective Serotonin Reuptake Inhibitor (SSRI)
first line - sertraline (unlicensed)
Response increases over time
If effective treat for one year
Alternative SSRI or SNRI second line
Offer pregabalin 3rd line
Benzodiazepines for short term use only in severe anxiety state (crisis)
DO NOT use antipsychotic
Shared decision
Anxiolytics
Panic disorder treatment
Psychological therapy
Offer individualised cognitive behavioural therapy (CBT)
- Over 1-2 hours for each weekly session
- Max 4 months of treatment
Facilitated or non-facilitated self help materials - groups and exercise
If not effective, add in pharmacotherapy
Pharmacological therapy
Less evidence of longer duration of positive effects than CBT
Consider OD/harm risk, patient
preference/history/co-morbidities/other meds
Treatment choice:
-Selective Serotonin Reuptake Inhibitor (SSRI)
first line - any licensed for panic disorder eg peroxitine, sertraline, citalopram
Second line - use imipramine or clomipramine (tricyclic antidepressants)
Give up to 12 weeks to see if medication working but see patient every two weeks for updates
-If treatment successfully used for 6 months dose can be tapered and stopped
-DO NOT use benzodiazepines (BZDs), antipsychotics, sedating antihistamines
Social anxiety / phobia disorder treatment
Psychological therapy
Offer individualised cognitive behavioural therapy (CBT)(workbook and activities with counsellor)
- Clark and Wells model (education and video feedback to build self esteem )
- Heimberg model (exposure therapy)
Those who decline CBT may be offered CBT-based self help
Combine CBT with pharmacological approaches if partial/limited response
Psychodynamic therapy last line
Pharmacological therapy
Offered to those who:
Partially respond to CBT
Do not want psychological therapy
Treatment choice:
Selective Serotonin Reuptake Inhibitor (SSRI)
first line - sertraline/escitalopram (10-12 weeks for full effect)
Alternative SSRI or SNRI second line - venlafaxine/fluvoxamine/ peroxitine
Mono-amine oxidase inhibitor (MAOl) 3d line - moclobemide/phenelzine
DO NOT use benzodiazepines (BZDs), tri-cyclic antidepressants (TCAs), antipsychotics, St Johnās
Wort or anticonvulsants
Considerations for antidepressants on anxiety disorders
⢠Treatment may take 2 weeks or more to work - short term treatment with benzodiazepines may be required
⢠Important ADRs (side-effects) for antidepressants are anxiety, Gl disturbances, anorexia, insomnia, agitation and suicidal thoughts/behaviours
⢠Careful monitoring for those aged under 30 / prior suicide risks
⢠Careful with dosing SSRIs in GAD and/or panic disorder (starting doses may be lower than for depression but can go higher)
⢠Other pharmacological options for anxiety that are not in NICE guidelines
Propranolol for physical symptoms of anxiety, useful in situational stress (no effect on psychological / non-autonomic symptoms) (palpitations/ shortness of breath/ sweating) (treats symptoms not underlying cause)
Buspirone for GAD (5HT1 partial agonist)(short term options for severe anxiety)
Treatment points
⢠Please see lectures from Joanne Nguyen and Mike Harte on antidepressant side effects and important pharmaceutical care considerations across different classes (e.g. hyponatraemia, serotonin syndrome, QT prolongation, risks in cardiac disease)
⢠Benzodiazepines - see lecture part 3 for risks
⢠Pregabalin now a schedule 3 controlled drug due to its abuse potential.
⢠General lifestyle advice: make time for relaxation, try to optimise exercise, alcohol reduction
⢠Treatment resistance, suicide risk and substance misuse prompt specialist referral
Medicine optimisation in anxiety summary
⢠Rule out other (preventable) causes of anxiety symptoms.
⢠Non-pharmacological methods usually first line treatment for anxiety
⢠Tailor drug treatment for anxiety to individual patient wishes/history
- SRis main first line drug treatment for moderate-severe anxiety disorders
- Other options: SNRI, TCA, pregabalin, MAOI
- Adjunctive treatments: propranolol, buspirone, others
⢠Prescribing advice: selecting and initiating antidepressant treatment
⢠Education: limited role of BZD in anxiety disorders, associated risks and withdrawal regime
⢠Patient counselling: drug choice, initiation and important side effects
Insomnia factors
Drugs
Life events
The environment
Illness
3 types of insomnia & symptoms
Can be transient, acute or chronic insomnia
⢠Transient - sleep well usually. Jet lag, shift work, noise/light disturbance
⢠Short term - may last for a few weeks, bereavement, physical illness
ā¢āChronic insomnia can be defined as an inability to achieve or maintain sleep satisfactorily on the majority of nights (3+ per week) over a period of at least three months, despite adequate opportunity, with subsequent adverse consequences on daily functioningā
Irritable , cognitively impaired, tired during the day
Sleep condition indicator screening: over the month has sleep troubled you in general? If it has, how many nights per week are you troubled by poor sleep? Very low score can require further investigation
Patients may report one or more of the following:
⢠Difficulty in falling asleep
⢠Frequent waking during the night
⢠Early morning waking
⢠Daytime sleepiness
⢠General loss of well-being due to bad nightās sleep
Snoring heavily / frequently and restless legs may be a prompt for referral (sleep apnea)
Consider use of the two item sleep condition indicator for screening in primary care.
Insomnia treatment
Hypnotics - BZDs abd āZ drugsā
Before treatment, consider underlying causes
Drugs only for severe / interfering with daily life
CBTi - sleep restriction and stimulus control. Helps chronic insomnia by discussing patients thoughts and behaviour with sleep.
Sleepio (app)
Sleep hygiene approaches
These help explore sleep habits and patterns.
Hypnotics cannot cure insomnia - treat underlying causes if present
Sleep hygiene approaches
⢠Determine whether expectations of sleep are realistic
⢠Sleep diaries can be helpful - study sleep patterns, wakefulness, lifestyle factor
⢠Increase daily exercise (not in the evenings/within 4 hours of bedtime)
⢠Stop daytime naps
⢠The bedroom should be at the right noise and light levels, at the right temperature
⢠Reduce consumption of certain substances in the evenings (e.g. food and fluids, alcohol (interferes with REM sleep, more awakening, more time in non REM 1 and 2, less time in slow wave sleep) , chocolate, smoking, avoid caffeine after midday)
⢠Use the bed only for sleeping/sex, avoid TV/computers/devices in the bedroom
⢠Use relaxation techniques (e.g. Audio tools, breathing, counting methods)
⢠Develop a routine for rising and going to bed
⢠If you cannot sleep after 30 minutes, get up and do something else, then return
⢠Keep pets that disturb sleep out of the bedroom
Sleepio app
⢠Recommended by NICE May 2022 for use instead of sleep hygiene / hypnotics
⢠Costs £45 currently, NICE says more cost effective than usual treatment
⢠Involves
- Six week self-help programme, tailored approach, CBTi principles
- Sleep test and diary
⢠Medical assessment required before use in pregnancy and co-morbidities
⢠?Unclear if more effective than CBTi
3 insomnia non-drug approaches
Sleep hygiene
Sleepio app
CBTi
Insomnia drug treatment
Consider tolerance and dependence (addiction) (taper down gradually)
⢠Use pharmacological āhypnoticā agents (BZD and Z drugs):
⢠For the shortest time period (usually 2 weeks, max 4 weeks, see SmPCs)
⢠For one or two doses, or intermittently if possible
⢠At the lowest effective dose
⢠If severe transient/short term insomnia, a few doses may be sufficient
⢠Additive sedative effects with alcohol (avoid) and other sedating drugs (e.g. clozapine)
⢠No difference between BZDs and āZ drugā hypnotics in terms of efficacy (just side effects and tolerability)
⢠Prescribe the agent with the lowest acquisition cost
⢠Could use shorter acting agent if difficulty falling asleep
But increased risk of tolerance/dependence and late night rebound insomnia
Temazepam (Benzodiazepine), Zolpidem (Z drug)
⢠Could use longer acting agent if frequent and/or early morning wakening
Be mindful of next day sedation and loss of co-ordination (āhangoverā effect)
Longer acting agents less likely to cause rebound insomnia
Nitrazepam (Benzodiazepine), Zopiclone (Z drug)
⢠Reduce doses slowly if patients have used hypnotics for a prolonged period
⢠Monitor carefully for rebound insomnia and withdrawal symptoms
⢠The risks of treating older people with hypnotics may outweigh the benefits (increases falls risk and hip fracture)
Other insomnia drug treatments
CBT-I may be better than hypnotics longer term (see directed reading)
⢠Melatonin
- Mimics natural melatonin: not addictive and well tolerated, does not cause tolerance
- Usual dose 2mg daily, licensed as monotherapy for over 55ās, very short acting (often appears as MR prep) - promotes sleep initiation and uninterrupted sleep
⢠Sedating antihistamines
- Diphenhydramine, chlorphenamine and promethazine
- Can be purchased OTC, have mild-moderate effects but commonly produce āhangoverā ADRs and tolerance can develop to effects. Can also produce a āhighā
⢠Clomethiazole
- Dependence/tolerance and respiratory depression in overdose limit use
⢠Over the counter (OTC) preparations (avoid)
- Very small evidence base
⢠Valerian-hops combinations |
⢠Passion-flower
⢠Jamaica Dogwood (toxic)
Melatonin
Can cause toxicity episodes
⢠Increasing use of melatonin in young people
- Generally high levels of melatonin when younger, falling levels as getting older
- Being driven by increasing diagnosis of certain conditions?
⢠Perception it is āsafeā - but lacking long term safety data
- Timing also important
- Parents may be reluctant to stop it once started
- Increasing toxicity episodes in US
⢠Only likely to be effective in circadian rhythm disorders
⢠Specific licensing - lots of use outside?
- Short term use
- Adults: jet lag, age 55+, learning difficulties
- Children: Learning difficulties, sleep onset disorder, autism and ADHD
Daridorexant
For chronic insomnia affecting at least 3 nights per week and lasting at least 3 months, not responding to sleep hygiene and/or CBTi (so it is a second line option)
Orexin antagonist (regulates wakefulness)
Review regularly and stop if not an adequate response
May worsen depression and suicidal ideation, and in other disorders too. Can cause dizziness and drowsiness, hallucinations, sleep paralysis
⢠Review regularly and stop if not an adequate response, caution in mental illness
Medicines optimisation insomnia summary
⢠Try non-pharmacological methods and explore cause(s) first unless severe
⢠Try to avoid BZD and Z drugs in high risk groups
⢠Choose hypnotic agents based of half life and symptom presentation
⢠Enforce practical prescribing of BZD and Z drugs, Daridorexant an option if chronic symptoms
⢠Patient counselling r.e. appropriateness of BZD and Z drugs for insomnia
⢠Patient counselling r.e. alternative treatments for insomnia (e.g. OTCs)
⢠Education r.e. effectiveness & tolerance/dependence with BZD/Z drugs